Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions
Nat Rev Drug Discov
.
2022 Jul;21(7):541.
doi: 10.1038/s41573-022-00503-6.
Authors
Fabien Vincent
1
,
Arsenio Nueda
2
,
Jonathan Lee
3
,
Monica Schenone
4
,
Marco Prunotto
5
6
,
Mark Mercola
7
Affiliations
1
Discovery Sciences, Worldwide Research, Development and Medical, Pfizer, Groton, CT, USA. Fabien.Vincent@pfizer.com.
2
Department of Biology, Almirall Research & Development, Barcelona, Spain.
3
PDD4Patients LLC, Indianapolis, IN, USA.
4
Medicine Design, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA.
5
Technology and Translational Research, Roche, Basel, Switzerland.
6
School of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
7
Department of Medicine, Stanford University, Palo Alto, CA, USA.
PMID:
35688887
DOI:
10.1038/s41573-022-00503-6
No abstract available
Publication types
Published Erratum